Xu J - Search Results

1

Spirolactone-type and enmein-type derivatives as potential anti-cancer agents derived from oridonin.

Ni X, He C, Jia Y, Wu X, Zhou K, Xu S, Xu J, Yao H. Ni X, et al. Among authors: xu s, xu j. Bioorg Med Chem. 2022 Oct 15;72:116977. doi: 10.1016/j.bmc.2022.116977. Epub 2022 Aug 25. Bioorg Med Chem. 2022. PMID: 36037626

2

Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivatives.

Bi Y, Xu J, Wu X, Ye W, Yuan S, Zhang L. Bi Y, et al. Among authors: xu j. Bioorg Med Chem Lett. 2007 Mar 1;17(5):1475-8. doi: 10.1016/j.bmcl.2006.09.096. Epub 2006 Oct 4. Bioorg Med Chem Lett. 2007. PMID: 17275295

3

Synthesis and biological activity of 2-alkylbenzimidazoles bearing a N-phenylpyrrole moiety as novel angiotensin II AT1 receptor antagonists.

Xu JY, Zeng Y, Ran Q, Wei Z, Bi Y, He QH, Wang QJ, Hu S, Zhang J, Tang MY, Hua WY, Wu XM. Xu JY, et al. Bioorg Med Chem Lett. 2007 May 15;17(10):2921-6. doi: 10.1016/j.bmcl.2007.02.042. Epub 2007 Feb 20. Bioorg Med Chem Lett. 2007. PMID: 17412584

4

Synthesis and biological evaluation of novel 1-O- and 14-O-derivatives of oridonin as potential anticancer drug candidates.

Xu J, Yang J, Ran Q, Wang L, Liu J, Wang Z, Wu X, Hua W, Yuan S, Zhang L, Shen M, Ding Y. Xu J, et al. Bioorg Med Chem Lett. 2008 Aug 15;18(16):4741-4. doi: 10.1016/j.bmcl.2008.06.097. Epub 2008 Jul 3. Bioorg Med Chem Lett. 2008. PMID: 18644718

5

Total synthesis and antihypertensive activity of (+/-)7,8-dihydroxy-3-methyl-isochromanone-4.

Liu J, Ren H, Xu J, Bai R, Yan Q, Huang W, Wu X, Fu J, Wang Q, Wu Q, Fu R. Liu J, et al. Among authors: xu j. Bioorg Med Chem Lett. 2009 Mar 15;19(6):1822-4. doi: 10.1016/j.bmcl.2008.12.102. Epub 2008 Dec 31. Bioorg Med Chem Lett. 2009. PMID: 19233642

6

Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.

Zhu P, Bi Y, Xu J, Li Z, Liu J, Zhang L, Ye W, Wu X. Zhu P, et al. Among authors: xu j. Bioorg Med Chem Lett. 2009 Dec 15;19(24):6966-9. doi: 10.1016/j.bmcl.2009.10.055. Epub 2009 Nov 2. Bioorg Med Chem Lett. 2009. PMID: 19889536

7

The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.

Wang L, Li D, Xu S, Cai H, Yao H, Zhang Y, Jiang J, Xu J. Wang L, et al. Among authors: xu s, xu j. Eur J Med Chem. 2012 Jun;52:242-50. doi: 10.1016/j.ejmech.2012.03.024. Epub 2012 Mar 23. Eur J Med Chem. 2012. PMID: 22483090

8

Synthesis and biological evaluation of novel furozan-based nitric oxide-releasing derivatives of oridonin as potential anti-tumor agents.

Li D, Wang L, Cai H, Zhang Y, Xu J. Li D, et al. Among authors: xu j. Molecules. 2012 Jun 18;17(6):7556-68. doi: 10.3390/molecules17067556. Molecules. 2012. PMID: 22710829 Free PMC article.

9

Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists.

Bai R, Wei Z, Liu J, Xie W, Yao H, Wu X, Jiang J, Wang Q, Xu J. Bai R, et al. Among authors: xu j. Bioorg Med Chem. 2012 Aug 1;20(15):4661-7. doi: 10.1016/j.bmc.2012.06.011. Epub 2012 Jun 15. Bioorg Med Chem. 2012. PMID: 22750010

10

Synthesis and biological activity of 28-amide derivatives of 23-hydroxy betulinic Acid as antitumor agent candidates.

Bi Y, Xu J, Sun F, Wu X, Ye W, Sun Y, Huang W. Bi Y, et al. Among authors: xu j. Med Chem. 2013 Nov;9(7):920-5. doi: 10.2174/1573406411309070005. Med Chem. 2013. PMID: 23083117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67,605 results

Search Page

Filters